Texas Centers for Infectious Disease Associates P.A. (Site 2709)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• HIV

Closed trials

• Completed

  Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]

  NCT04564547· Phase 2· Merck Sharp & Dohme LLC· Source